The company’s shares closed last Friday at $18.31. Matteis covers the Healthcare sector, focusing on stocks such as ACADIA Pharmaceuticals, BioMarin Pharmaceutical, and Alkermes. According to TipRanks ...

For patients with opioid use disorder (OUD), a rapid procedure (RP) is noninferior to a standard procedure for initiation of ...

In a report released yesterday, Paul Matteis from Stifel Nicolaus maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Psychiatrists and mental health professionals have a new standard for managing major depression, thanks to refreshed clinical guidelines published today by the Canadian Network for Mood and Anxiety ...

Alkermes plc last week announced it had completed the sale of its development and manufacturing facility in Athlone, to Novo ...

TARO Taro Pharmaceutical Industries Ltd.

Because this plan is a short plan based on a test of resistance it is referred to as a Short Resistance Plan. Check the time stamp on this data. Updated AI-Generated Signals for Alkermes Plc (ALKS) ...

Leveraging my background as an RN with a BSN and current MBA studies, my investment analyses in biotech marry clinical insight with strategic business perspectives. I utilize risk-return charts to ...